Literature DB >> 30777221

Dose of CT protocols acquired in clinical routine using a dual-layer detector CT scanner: A preliminary report.

F van Ommen1, H W A M de Jong2, J W Dankbaar3, E Bennink4, T Leiner5, A M R Schilham6.   

Abstract

PURPOSE: To assess the radiation dose associated with always-on dual-energy acquisitions in clinical practice over a broad range of clinical protocols using a dual-layer detector CT (DLCT; IQon spectral CT, Philips Healthcare) as compared to an otherwise technically equivalent single-layer detector CT (SLCT; Brilliance iCT, Philips healthcare).
MATERIALS AND METHODS: Dose-length-product data for consecutive examinations over a six-month period acquired with DLCT were retrospectively collected and compared to consecutive examinations from an SLCT. Imaging protocols were optimized for diagnostic image quality for each system prior to data collection. Dose reports of CT protocols that were used at least 50 times on both systems were collected. After exclusion of statistical outliers, protocols were evaluated with regard to reported dose levels.
RESULTS: In total, 4536 dose reports for DLCT and 5783 reports for SLCT were collected. All DLCT examinations were acquired at 120 kVp, enabling dual-energy analysis. With SLCT, 79% of examinations were acquired at 120 kVp, and 21% at 100/80 kVp. Protocols for 15 indications were used more than 50 times on both scanners. For seven protocols there was no significant difference between the two scanners (p > 0.05), whereas seven protocols were acquired with higher dose levels on SLCT compared to the DLCT (p < 0.03). For one protocol, the DLCT dose was significantly higher (p < 0.005) compared to the SLCT.
CONCLUSION: Dual-layer detector CT enables acquisition of dual-energy information over a broad range of clinical indications without increasing radiation dose when compared to a conventional single-layer detector CT.
Copyright © 2019 Elsevier B.V. All rights reserved.

Keywords:  Clinical routine; Dual-energy CT; Dual-layer detector CT; Radiation dose; Single-layer detector CT

Mesh:

Year:  2019        PMID: 30777221     DOI: 10.1016/j.ejrad.2019.01.011

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

1.  Early reduction in spectral dual-layer detector CT parameters as favorable imaging biomarkers in patients with metastatic renal cell carcinoma.

Authors:  Finn Rasmussen; Frede Donskov; Aska Drljevic-Nielsen; Jill R Mains; Kennet Thorup; Michael Brun Andersen
Journal:  Eur Radiol       Date:  2022-05-05       Impact factor: 5.315

2.  Virtual monoenergetic images preserve diagnostic assessability in contrast media reduced abdominal spectral detector CT.

Authors:  Simon Lennartz; Nils Große Hokamp; Charlotte Zäske; David Zopfs; Grischa Bratke; Andreas Glauner; David Maintz; Thorsten Persigehl; De-Hua Chang; Tilman Hickethier
Journal:  Br J Radiol       Date:  2020-07-24       Impact factor: 3.039

3.  Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients.

Authors:  Michael Brun Andersen; Dyveke Ebbesen; Jesper Thygesen; Matthijs Kruis; Finn Rasmussen
Journal:  Eur Radiol       Date:  2020-05-04       Impact factor: 5.315

4.  Breast cancer: comparison of quantitative dual-layer spectral CT and axillary ultrasonography for preoperative diagnosis of metastatic axillary lymph nodes.

Authors:  Thomas Winther Buus; Mads Sandahl; Kennet Sønderstgaard Thorup; Finn Rasmussen; Søren Redsted; Peer Christiansen; Anders Bonde Jensen; Erik Morre Pedersen
Journal:  Eur Radiol Exp       Date:  2021-04-09

5.  Utility of dual-layer spectral-detector CT imaging for predicting pathological tumor stages and histologic grades of colorectal adenocarcinoma.

Authors:  Weicui Chen; Yongsong Ye; Daochun Zhang; Liting Mao; Lei Guo; Hanliang Zhang; Xiaohua Du; Weiwei Deng; Bo Liu; Xian Liu
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

6.  Dual-Layer Spectral CT Imaging of Upper Aerodigestive Tract Cancer: Analysis of Spectral Imaging Parameters and Impact on Tumor Staging.

Authors:  C C-T Hsu; C Jeavon; I Fomin; L Du; C Buchan; T W Watkins; Y Nae; N M Parry; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-29       Impact factor: 4.966

7.  Image quality evaluation of dual-layer spectral CT in comparison to single-layer CT in a reduced-dose setting.

Authors:  Thuy Duong Do; Stephan Rheinheimer; Hans-Ulrich Kauczor; Wolfram Stiller; Tim Weber; Stephan Skornitzke
Journal:  Eur Radiol       Date:  2020-05-11       Impact factor: 5.315

Review 8.  Radiation dose reduction considerations and imaging patterns of ground glass opacities in coronavirus: risk of over exposure in computed tomography.

Authors:  Mohammad Ahmmad Rawashdeh; Charbel Saade
Journal:  Radiol Med       Date:  2020-09-08       Impact factor: 6.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.